US Stock MarketDetailed Quotes

Kiniksa Pharmaceuticals International (KNSA)

Watchlist
  • 39.090
  • +1.170+3.09%
Trading Jan 16 15:03 ET
2.96BMarket Cap86.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiniksa Pharmaceuticals International (KNSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
61.17%180.86M
44.34%156.8M
72.54%137.79M
56.60%423.24M
46.93%122.54M
67.37%112.21M
51.99%108.63M
65.18%79.86M
22.74%270.26M
34.76%83.4M
Operating revenue
61.17%180.86M
44.34%156.8M
72.54%137.79M
56.60%423.24M
46.93%122.54M
67.37%112.21M
51.99%108.63M
65.18%79.86M
22.74%270.26M
34.76%83.4M
Cost of revenue
69.10%83.56M
67.76%71.02M
96.46%61.66M
110.41%189.22M
149.16%66.09M
87.19%49.42M
95.23%42.34M
104.80%31.38M
91.48%89.93M
86.36%26.52M
Gross profit
54.93%97.29M
29.39%85.78M
57.05%76.13M
29.77%234.02M
-0.74%56.45M
54.50%62.8M
33.15%66.3M
46.80%48.47M
4.11%180.33M
19.35%56.87M
Operating expense
1.12%73.27M
-1.20%65.62M
-3.32%62.86M
36.06%279.63M
33.38%75.75M
40.49%72.46M
25.44%66.41M
47.04%65.02M
25.75%205.52M
36.50%56.79M
Selling and administrative expenses
5.83%49.1M
10.54%46.86M
12.53%43.53M
29.81%168.01M
10.33%40.54M
34.61%46.4M
45.31%42.4M
33.18%38.68M
32.13%129.43M
35.00%36.74M
Research and development costs
-7.26%24.17M
-21.92%18.75M
-26.62%19.33M
46.69%111.62M
75.62%35.22M
52.33%26.06M
1.05%24.02M
73.57%26.33M
16.20%76.1M
39.35%20.05M
Other operating expenses
----
----
----
127.00%128.31M
----
----
----
----
134.82%56.52M
----
Operating profit
348.72%24.02M
17,330.77%20.16M
180.23%13.27M
-81.04%-45.62M
-23,925.93%-19.3M
11.61%-9.66M
96.29%-117K
-47.75%-16.54M
-357.81%-25.2M
-98.66%81K
Net non-operating interest income expense
Other net income (expense)
27.64%3.14M
12.23%2.72M
1.19%2.29M
10.77%9.46M
-2.07%2.32M
1.19%2.46M
26.42%2.42M
23.69%2.27M
581.88%8.54M
198.36%2.37M
Other non- operating income (expenses)
27.64%3.14M
12.23%2.72M
1.19%2.29M
10.77%9.46M
-2.07%2.32M
1.19%2.46M
26.42%2.42M
23.69%2.27M
581.88%8.54M
198.36%2.37M
Income before tax
477.13%27.16M
892.93%22.88M
209.03%15.57M
-117.10%-36.15M
-793.02%-16.98M
15.27%-7.2M
285.96%2.3M
-52.46%-14.28M
-251.02%-16.65M
-64.19%2.45M
Income tax
58.81%8.72M
-18.79%5.05M
104.96%7.03M
122.91%7.04M
64.49%-8.09M
2.54%5.49M
138.32%6.21M
17.96%3.43M
82.17%-30.74M
-1,057.44%-22.79M
Net income
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
Net income continuous Operations
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
Minority interest income
Net income attributable to the parent company
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
Basic earnings per share
238.89%0.25
500.00%0.24
148.00%0.12
-400.00%-0.6
-133.33%-0.12
10.00%-0.18
-128.57%-0.06
-38.89%-0.25
-92.42%0.2
500.00%0.36
Diluted earnings per share
227.78%0.23
483.33%0.23
144.00%0.11
-400.00%-0.6
-134.29%-0.12
10.00%-0.18
-128.57%-0.06
-38.89%-0.25
-92.31%0.2
483.33%0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 61.17%180.86M44.34%156.8M72.54%137.79M56.60%423.24M46.93%122.54M67.37%112.21M51.99%108.63M65.18%79.86M22.74%270.26M34.76%83.4M
Operating revenue 61.17%180.86M44.34%156.8M72.54%137.79M56.60%423.24M46.93%122.54M67.37%112.21M51.99%108.63M65.18%79.86M22.74%270.26M34.76%83.4M
Cost of revenue 69.10%83.56M67.76%71.02M96.46%61.66M110.41%189.22M149.16%66.09M87.19%49.42M95.23%42.34M104.80%31.38M91.48%89.93M86.36%26.52M
Gross profit 54.93%97.29M29.39%85.78M57.05%76.13M29.77%234.02M-0.74%56.45M54.50%62.8M33.15%66.3M46.80%48.47M4.11%180.33M19.35%56.87M
Operating expense 1.12%73.27M-1.20%65.62M-3.32%62.86M36.06%279.63M33.38%75.75M40.49%72.46M25.44%66.41M47.04%65.02M25.75%205.52M36.50%56.79M
Selling and administrative expenses 5.83%49.1M10.54%46.86M12.53%43.53M29.81%168.01M10.33%40.54M34.61%46.4M45.31%42.4M33.18%38.68M32.13%129.43M35.00%36.74M
Research and development costs -7.26%24.17M-21.92%18.75M-26.62%19.33M46.69%111.62M75.62%35.22M52.33%26.06M1.05%24.02M73.57%26.33M16.20%76.1M39.35%20.05M
Other operating expenses ------------127.00%128.31M----------------134.82%56.52M----
Operating profit 348.72%24.02M17,330.77%20.16M180.23%13.27M-81.04%-45.62M-23,925.93%-19.3M11.61%-9.66M96.29%-117K-47.75%-16.54M-357.81%-25.2M-98.66%81K
Net non-operating interest income expense
Other net income (expense) 27.64%3.14M12.23%2.72M1.19%2.29M10.77%9.46M-2.07%2.32M1.19%2.46M26.42%2.42M23.69%2.27M581.88%8.54M198.36%2.37M
Other non- operating income (expenses) 27.64%3.14M12.23%2.72M1.19%2.29M10.77%9.46M-2.07%2.32M1.19%2.46M26.42%2.42M23.69%2.27M581.88%8.54M198.36%2.37M
Income before tax 477.13%27.16M892.93%22.88M209.03%15.57M-117.10%-36.15M-793.02%-16.98M15.27%-7.2M285.96%2.3M-52.46%-14.28M-251.02%-16.65M-64.19%2.45M
Income tax 58.81%8.72M-18.79%5.05M104.96%7.03M122.91%7.04M64.49%-8.09M2.54%5.49M138.32%6.21M17.96%3.43M82.17%-30.74M-1,057.44%-22.79M
Net income 245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M
Net income continuous Operations 245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M
Minority interest income
Net income attributable to the parent company 245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M
Basic earnings per share 238.89%0.25500.00%0.24148.00%0.12-400.00%-0.6-133.33%-0.1210.00%-0.18-128.57%-0.06-38.89%-0.25-92.42%0.2500.00%0.36
Diluted earnings per share 227.78%0.23483.33%0.23144.00%0.11-400.00%-0.6-134.29%-0.1210.00%-0.18-128.57%-0.06-38.89%-0.25-92.31%0.2483.33%0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.31%
Sample Name
Sample Code
 +2.69%
Sample Name
Sample Code
 +2.63%
4
Broadcom
AVGO
+2.41%
5
Block
XYZ
+1.29%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +10.43%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.17%
5
United Microelectronics
UMC
+6.20%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -